Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Eli Lilly Shares Slide as Price Cuts Batter Its Diabetes Business in China
10:39pm, Monday, 29'th Nov 2021 GuruFocus
Novo Nordisk and Sanofi also forced to shave prices for insulin products Related Stocks: LLY , NVO , SNY , XTER:BAYN , PFE , AZN ,
Antibacterial Drugs Market SWOT Analysis by Key Players Sanofi, Allergan (AbbVie), GSK, Merck
02:32pm, Monday, 29'th Nov 2021 OpenPR
HTF MI introduce new research on Global Antibacterial Drugs covering micro level of analysis by competitors and key business segments. The Global Antibacterial Drugs explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of
Sleep Aids Market Booming Worldwide Report 2021-2028 | Sanofi S.A., Merck & Co, Pfizer, Koninklijke Philips N.V
11:20am, Monday, 29'th Nov 2021 OpenPR
Overview Some of the common side effects of prescription sleeping pills include feeling extremely tired during the day, difficulty concentrating and remembering things, and experiencing anxiety while sleeping. While the above side effects may be annoying for some, they should be
Neonatal Hypoxic-Ischemic Encephalopathy market research report has vital data about the market, emerging trends, product usage, motivating factors for customers and competitors. Market restraints, brand positioning, and customer behaviour is also studied in the document with which achieving a success
Sanofi (NASDAQ:SNY) Receives $51.00 Consensus Target Price from Analysts
03:50pm, Sunday, 28'th Nov 2021 Transcript Daily
Sanofi (NASDAQ:SNY) has been assigned an average rating of Buy from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The average 1 []
A Trio of International Health Care Stocks for Income
05:00pm, Friday, 26'th Nov 2021
U.S. investors often focus on owning domestic companies, as this is the region of the world they are likely most familiar with. As such, this can limit the number of quality stocks available to them f
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Diabetes Mellitus, Date of authorisation: 25/06/2020, Revision: 3, Status: Authorised
03:28pm, Friday, 26'th Nov 2021 EU Medicines Agency
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Diabetes Mellitus, Date of authorisation: 25/06/2020, Revision: 3, Status: Authorised
Encube to buy anti-microbial brand Soframycin from Sanofi for Rs 125 cr
02:48pm, Friday, 26'th Nov 2021 Business Standard
Will also acquire other legacy associated brands such as Sofradex (antibacterial cream), Sofracort (eye and ear drops), Soframycin-Tulle (cream) for India and Sri Lanka markets
Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi
11:54am, Friday, 26'th Nov 2021 Express Pharma
The transaction is expected to close within the next three months The post Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi appeared first on Express Pharma .
Human Rabies Immunoglobulin Market Growth 2021 | Market Trends, Covid-19 Impact, Business Outlook 2027 |CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang
11:53am, Friday, 26'th Nov 2021 OpenPR
The global Human Rabies Immunoglobulin (IM) market was valued at 27.93 Million USD in 2020 and will grow with a CAGR of 7.34% from 2021 to 2027. According to a research report performed by Infinity Business Insights analysts, the Human
Meningococcal Vaccines Market to Show Incredible Growth by 2027 Covid-19 Analysis | Sanofi, Pfizer, Baxter International,
11:14am, Friday, 26'th Nov 2021 OpenPR
The global meningococcal vaccine market is expected to grow significantly during the forecast period, thanks to increased adoption in national immunisation programmes in a number of countries around the world. Furthermore, a rise in meningococcal outbreaks in several countries has
Osteoarthritic Pain Market Detail Analysis focusing on Key Players like GSK, Abbott, Pfizer, Merck, Mylan, Sanofi, Bayer, Teva | Forecasts 2021-2028
10:50am, Friday, 26'th Nov 2021 OpenPR
Overview of Global Osteoarthritic Pain Market: Osteoarthritic Pain Market research report gives analysis and data according to categories such as Market segments, regions, types, technology, end-user, applications and so on. The report offers current industry data and upcoming trends of the
Small Molecule Prefilled Syringes Market SWOT Analysis Report 2021-2028 | Sanofi, Viatris, AstraZeneca Plc, F. Hoffmann-La Roche AG
10:46am, Friday, 26'th Nov 2021 OpenPR
Availability of a wide variety of products for small molecule prefilled syringe products (branded and generic), benefits over conventional forms of dosage forms (instant effect) including capsules and tablets, and rising acceptance of products of small molecule prefilled syringe is
Accurate market intelligence can be obtained with the help of SWOT analysis provided in the first class Parathyroid adenoma market report that aid businesses identify opportunities as well as both internal and external influences. With the wonderful secondary research expertise
Wide-Moat Stocks On Sale - The December 2021 Heat Map
06:28am, Friday, 26'th Nov 2021
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
